FDA campaign H-0687-2026
Class IIIHazard
The potential contamination with Clostridium botulinum, due to risk of temperature abuse during chilled storage at the firm
Distribution
NY, VT, PA
REKALLD area-alert coverage: NY, PA, VT (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.